The Role of Granulocyte-Colony Stimulating Factor (G-CSF) in the Healthy Brain: A Characterization of G-CSF-Deficient Mice

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

Figure 4.
Figure 4.

Quantification of neurogenesis by the detection of BrdU/NeuN- and DCX-expressing cells. A, Immunodetection of BrdU in the dentate gyrus of wild-type mice (upper micrograph) and G-CSF−/− mice (lower micrograph). G-CSF deficiency led to a significant reduction in the total amount of BrdU-positive cells (mean G-CSF−/−, 1944 ± 253.31 SEM; mean wild type, 6873 ± 433.09; p < 0.001, Student's t test) and BrdU/NeuN-positive cells (mean G-CSF−/−, 1634.11 ± 189.56 SEM; mean wild type, 5690.69 ± 319.77; p < 0.001, Student's t test). Scale bar, 80 μm. B, Immunodetection of DCX in the dentate gyrus of wild-type mice (upper micrograph) and G-CSF−/− mice (lower micrograph). G-CSF deficiency led to a significant reduction in the amount of DCX-expressing cells compared with wild-type mice (mean G-CSF−/−, 8004 ± 3011.07 SEM; mean wild type, 34,752 ± 11,317.28; p < 0.05, Student's t test). Scale bar, 80 μm

  1. The Journal of Neuroscience vol. 29 no. 37 11572-11581
Responses to This Article
Be the first to respond to this article
Advertisement